Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 6/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | MGAM | O43451 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | SI | P14410 | 1/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetraethylene Glycol SCHEMBL3187646 | 1.00 | THRB (0.55) | THRBALDH1A1MEN1KMT2ATSHR | |
| Di(Hydroxyethyl)Ether SCHEMBL1412254 | 0.98 | ALDH1A1 (0.56) | THRBALDH1A1MEN1KMT2ATSHR | |
| 2-Ethoxyethanol SCHEMBL18130031 | 0.93 | THRB (0.58) | THRBALDH1A1MEN1KMT2ATSHR | |
| SCHEMBL8625374 | 0.93 | ALDH1A1 (0.62) | THRBALDH1A1MEN1KMT2ATSHR | |
| Triethylene Glycol SCHEMBL2770781 | 0.93 | ALDH1A1 (0.62) | THRBALDH1A1MEN1KMT2ATSHR | |
| Pentaethylene Glycol SCHEMBL9580843 | 0.93 | ALDH1A1 (0.62) | THRBALDH1A1MEN1KMT2ATSHR | |
| Tetraethylene Glycol SCHEMBL27952589 | 0.93 | ALDH1A1 (0.62) | THRBALDH1A1MEN1KMT2ATSHR | |
| Di(Hydroxyethyl)Ether SCHEMBL1483510 | 0.91 | ALDH1A1 (0.65) | THRBALDH1A1MEN1KMT2ATSHR | |
| Di(Hydroxyethyl)Ether SCHEMBL27881167 | 0.91 | ALDH1A1 (0.65) | THRBALDH1A1MEN1KMT2ATSHR | |
| Tetraethylene Glycol SCHEMBL2568199 | 0.87 | ALDH1A1 (0.56) | THRBALDH1A1MEN1KMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 370 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4479101-B1 | PHOTOPOLYMERISABLE COMPOSITION FOR ADHESIVE FOR BIOLOGICAL TISSUE | COHESIVES (FR) | 2026-03-04 | — | — | EP | claimed |
| US-20250381318-A1 | INTRAOCULAR LENS COMPOSITIONS | Teleon Holding B.V. (NL) | 2025-12-18 | — | — | US | claimed |
| EP-3934705-B1 | INTRAOCULAR LENS COMPOSITIONS | TELEON HOLDING B V (NL) | 2025-11-19 | — | — | EP | claimed |
| US-12427226-B2 | Intraocular lens compositions | Teleon Holding B.V. (NL) | 2025-09-30 | — | — | US | claimed |
| US-20250205360-A1 | FUNCTIONALIZED CORE-SHELL NANOGEL SCAVENGER FOR IMMUNE MODULATION THERAPY | UNIV NEW YORK STATE RES FOUND (US) | 2025-06-26 | — | — | US | claimed |
| US-20250152772-A1 | PHOTOPOLYMERISABLE COMPOSITION FOR ADHESIVE FOR BIOLOGICAL TISSUES | COHESIVES (FR) | 2025-05-15 | — | — | US | claimed |
| WO-2025072355-A1 | METHODS FOR AND COMPOSITIONS OF NON-PEG BIOCONJUGATES WITH ULTRA-HIGH DRUG-TO-AGENT RATIO | BIOHYBRID SOLUTIONS HOLDINGS, INC. (US) | 2025-04-03 | — | — | WO | claimed |
| EP-4479101-A1 | PHOTOPOLYMERISABLE COMPOSITION FOR ADHESIVE FOR BIOLOGICAL TISSUE | Cohesives (FR) | 2024-12-25 | — | — | EP | claimed |
| CN-118136967-B | Lithium metal battery and preparation method and application thereof | 蜂巢能源科技股份有限公司 | 2024-08-06 | — | — | CN | claimed |
| CN-118136967-A | Lithium metal battery and preparation method and application thereof | 蜂巢能源科技股份有限公司 | 2024-06-04 | — | — | CN | claimed |
| US-20160206522-A1 | MICROCAPSULES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-07-21 | — | — | US | claimed |
| CN-105431225-A | Microcapsule | TAKASAGO PERFUMERY CO LTD | 2016-03-23 | — | — | CN | claimed |
| US-20150252144-A1 | Biodegradable Cross-Linked Polymer, Vascular Stent and Manufacturing Methods Therefor | FARWAVE APPLIED MATERIAL (SHANGHAI) CO., LTD (CN) | 2015-09-10 | — | — | US | claimed |
| EP-2907834-A2 | BIODEGRADABLE CROSS-LINKED POLYMER, VASCULAR STENT AND MANUFACTURING METHODS THEREFOR | Shanghai MicroPort Medical (Group) Co., Ltd. (CN) | 2015-08-19 | — | — | EP | claimed |
| WO-2015016369-A1 | MICROCAPSULES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-02-05 | — | — | WO | claimed |
| EP-2832441-A1 | Microcapsules | Takasago International Corporation (JP) | 2015-02-04 | — | — | EP | claimed |
| US-20150021528-A1 | SOLUBLE FUNCTIONALIZED NANOPARTICLES FOR USE IN OPTICAL MATERIALS | STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF UNIVERSITY (US) | 2015-01-22 | — | — | US | claimed |
| EP-2764065-A1 | SACRIFICIAL ADHESIVE COATINGS | Rochal Industries, LLP (US) | 2014-08-13 | — | — | EP | claimed |
| WO-2013052276-A1 | SACRIFICIAL ADHESIVE COATINGS | ROCHAL INDUSTRIES, LLP (US) | 2013-04-11 | — | — | WO | claimed |
| US-8263720-B1 | Sacrificial adhesive coatings | ROCHAL INDUSTRIES, LLP (US) | 2012-09-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250205360-A1 | FUNCTIONALIZED CORE-SHELL NANOGEL SCAVENGER FOR IMMUNE MODULATION THERAPY | TST, CD44, TSLP | THRB 354/4885ALDH1A1 2745/4885MEN1 4701/4885 |
| US-20160206522-A1 | MICROCAPSULES | MITF, PLIN5, MLEC | THRB 2882/4885ALDH1A1 3127/4885MEN1 805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.